Mylan To Begin Selling Generic EpiPen In Wake Of Public, Congressional Criticism

(August 29, 2016, 10:42 AM EDT) -- PITTSBURGH — In the wake of public criticism and congressional questions, EpiPen maker Mylan N.V. on Aug. 29 announced that it will begin selling a generic version of the epinephrine injectors for half the $600 list price of the brand name device....

Related Sections